Mechanisms Mentioned in Abstracts
The title and abstract of the 3,056 records in the extended electroporation corpus were scanned for 30 mechanism names specific to the electroporation literature. The counts below show how often a mechanism is mentioned in the literature. A mechanism appearing in an abstract does not mean it was experimentally demonstrated in that study: it may equally have been mentioned in a rationale, a discussion or a negative finding.
From Mechanism to Clinical Effect
In the reversible regime the chain passes through drug entry; in the irreversible regime step 3 is skipped
Electrical Stimulus
A pulse train of controlled strength is applied between an electrode pair, producing an electric field distribution in the tissue.
Membrane Permeability
In cells where the induced transmembrane potential exceeds threshold, the membrane becomes transiently permeable.
Drug Entry
Bleomycin or cisplatin is carried into the cell; for bleomycin the reported increase in cytotoxicity ranges from several hundred to several thousand fold , .
Cell Death
DNA damage, mitotic catastrophe and apoptosis; in the irreversible regime, direct loss of homeostasis.
Tissue and Immune Response
Vascular lock, antivascular effect and systemic response components driven by immunogenic cell death.
Weight of the Mechanisms in the Literature
The bar is the share of records mentioning the mechanism within the extended electroporation corpus (3,056 records, including the non-oncological areas). The second bar below it is how that same figure divides between the regimes. The percentages on the right are not raw counts but the share within the area: the proportion of that area's publications mentioning the mechanism. An area is listed only from 4 publications upwards.
-
Reversible Membrane Permeabilisation Membrane Biophysics 1,328 publications 43%
ECT 126 IRE 918 Most concentrated in: Non-Oncological Electroporation 100% · Pancreatic Cancer 89% · Prostate & Urological Tumours 86%
-
Irreversible Pore Formation and Cell Death Membrane Biophysics 1,161 publications 38%
ECT 15 IRE 924 Most concentrated in: Cardiac Pulsed-Field Ablation 96% · Non-Oncological Electroporation 95% · Pancreatic Cancer 88%
-
Increased Intracellular Bleomycin Accumulation Drug Transport 562 publications 18%
ECT 465 IRE 11 Most concentrated in: Vascular Malformations 89% · Vulvar Cancer 48% · Veterinary Oncology 45%
-
Electric Field Distribution and Modelling Dose and Device 346 publications 11%
ECT 85 IRE 134 Most concentrated in: Brain Tumours 32% · General Principles & Biophysics 21% · Non-Oncological Electroporation 19%
-
Optimisation of Pulse Parameters Dose and Device 295 publications 10%
ECT 81 IRE 90 Most concentrated in: Nanosecond Pulsed Electric Field (nsPEF) 31% · Brain Tumours 23% · Lung & Peribronchial Tumours 22%
-
Gene Electrotransfer (Plasmid DNA) Gene and Immune Pathways 282 publications 9%
ECT 20 IRE 4 Most concentrated in: DNA Vaccination by Electroporation 75% · General Principles & Biophysics 18% · Malignant Melanoma 17%
-
Potentiation of Cytotoxic Drug Permeability Drug Transport 244 publications 8%
ECT 130 IRE 24 Most concentrated in: Vascular Malformations 16% · Brain Tumours 15% · General Principles & Biophysics 12%
-
Electrode Geometry and Placement Dose and Device 222 publications 7%
ECT 85 IRE 63 Most concentrated in: Vascular Malformations 13% · General Principles & Biophysics 11% · Bone & Soft Tissue Sarcomas 11%
-
Increased Intracellular Cisplatin Accumulation Drug Transport 213 publications 7%
ECT 180 IRE 7 Most concentrated in: Ovarian Tumours 60% · Veterinary Oncology 24% · Breast Cancer 14%
-
Apoptosis Induction Cell Death Pathways 202 publications 7%
ECT 43 IRE 90 Most concentrated in: Nanosecond Pulsed Electric Field (nsPEF) 39% · Brain Tumours 11% · Breast Cancer 10%
-
Necrosis and Necroptosis Cell Death Pathways 197 publications 6%
ECT 70 IRE 73 Most concentrated in: Cholangiocarcinoma 20% · Colorectal Cancer 14% · Liver Tumours 12%
-
Tissue Conductivity and Impedance Change Dose and Device 185 publications 6%
ECT 31 IRE 56 Most concentrated in: Devices & Clinical Trials 15% · General Principles & Biophysics 13% · Cardiac Pulsed-Field Ablation 8%
-
Muscle Contraction and Anaesthesia Requirement Dose and Device 164 publications 5%
ECT 84 IRE 47 Most concentrated in: Veterinary Oncology 15% · Colorectal Cancer 10% · Brain Tumours 9%
-
Thermal Effect and Joule Heating Dose and Device 133 publications 4%
ECT 3 IRE 102 Most concentrated in: Brain Tumours 15% · Nanosecond Pulsed Electric Field (nsPEF) 8% · General Principles & Biophysics 7%
-
Systemic / Abscopal Immune Response Gene and Immune Pathways 94 publications 3%
ECT 35 IRE 28 Most concentrated in: Veterinary Oncology 9% · Malignant Melanoma 8% · Pancreatic Cancer 6%
-
Calcium Electroporation and ATP Depletion Drug Transport 88 publications 3%
ECT 6 IRE 3 Most concentrated in: Colorectal Cancer 18% · Skin & Cutaneous Tumours 6% · Malignant Melanoma 4%
-
Interleukin-12 Mediated Immune Stimulation Gene and Immune Pathways 75 publications 2%
ECT 7 IRE 0 Most concentrated in: Malignant Melanoma 12% · Veterinary Oncology 11% · Skin & Cutaneous Tumours 3%
-
Mitochondrial Dysfunction and Oxidative Stress Cell Death Pathways 66 publications 2%
ECT 13 IRE 19 Most concentrated in: Nanosecond Pulsed Electric Field (nsPEF) 15% · Breast Cancer 8% · General Principles & Biophysics 3%
-
Preservation of Nerve and Vascular Structures Vascular and Tissue Effects 60 publications 2%
ECT 1 IRE 26 Most concentrated in: Cardiac Pulsed-Field Ablation 22% · Liver Tumours 2% · General Principles & Biophysics 1%
-
Immune Checkpoint Inhibitor Combination Gene and Immune Pathways 59 publications 2%
ECT 23 IRE 19 Most concentrated in: Malignant Melanoma 12% · Pancreatic Cancer 4% · Skin & Cutaneous Tumours 2%
-
Immunogenic Cell Death (ICD) Gene and Immune Pathways 58 publications 2%
ECT 16 IRE 27 Most concentrated in: Pancreatic Cancer 4% · Malignant Melanoma 4% · General Principles & Biophysics 2%
-
Nanosecond Pulsed Electric Field (nsPEF) Membrane Biophysics 55 publications 2%
ECT 6 IRE 7 Most concentrated in: Nanosecond Pulsed Electric Field (nsPEF) 62% · General Principles & Biophysics 1%
The 22 most frequently mentioned mechanisms are shown; all 30 names, with the spellings they match, are in the dictionary at the end of the page.
Mechanism Families
Each family's bar extends from the centre to the left for ECT and to the right for IRE record counts; the scale is shared across all six families. The list runs from the electrochemotherapy literature at the top to the irreversible electroporation literature at the bottom.
◀ ECTIRE ▶
-
Drug Transport 854 records 28%
582 38 -
Gene and Immune Pathways 450 records 15%
83 65 -
Dose and Device 902 records 30%
265 299 -
Cell Death Pathways 406 records 13%
109 156 -
Vascular and Tissue Effects 225 records 7%
52 101 -
Membrane Biophysics 1,503 records 49%
133 924
“Records” is the number of records mentioning at least one mechanism from that family. It is not the sum of the member counts, because one record may mention several mechanisms from the same family, and for the same reason the six families add up to more than 3,056 records. Nor do the ECT and IRE counts add up to the family total: the difference is records of calcium electroporation, gene electrotransfer and records whose method could not be determined. The full list of names is in the dictionary below.
What This Count Measures, and What It Does Not
The figures on this page come from a dictionary. It is published in full below, with the spellings each name matches and its search patterns. What the figures measure, and what they do not, is defined in this section.
What was scanned. The title, the abstract and, for records without one, the opening paragraph of the PDF. Full text is not scanned: the PDF body, tables, figure captions and reference lists are out of scope, and a mechanism appearing only in the full text does not show up in these counts. Matching is case-insensitive and is a substring match: the name “potentiat” also matches inside “potentiation” and “potentiated”. However many times a name occurs in a record, that record is counted once for it.
Negation is not distinguished. No negation, context or exclusion rule is defined that would stop a name from being counted. The sentence “no evidence of apoptosis” also matches the name “apoptosis”; the dictionary does not distinguish whether the sentence containing it is positive or negative. Only two structural limits narrow the count, and neither of them is contextual: (1) at most 6 mechanism names are kept per record, selected by which names occur most often in that record, so names further down the ranking go uncounted in publications that discuss many mechanisms; (2) outcome domains are counted only in clinical publications (primary clinical studies, case series and case reports), leaving preclinical and secondary publications outside this count.
A mention is not evidence. A mechanism appearing in an abstract does not mean that the mechanism or the outcome was demonstrated in that study. The name may equally appear in a rationale, a discussion of methods, a summary of the literature, a limitation or a negative finding. This page shows what the literature talks about, not what it establishes; no row should be read as an indicator of efficacy, safety or success.
Open the full dictionary: 30 mechanism names and 10 outcome domains with the spellings they match
In each entry the line under the name gives the spellings the search pattern matches. The binding definition is the pattern itself; this list is its readable counterpart.
Mechanism names
Membrane Biophysics 4 names
-
Reversible Membrane Permeabilisation ECT 126IRE 918
reversible electroporation · reversible permeabili · membrane permeabili · electropermeabili
Search pattern: reversible electroporation|reversible permeabili|membrane permeabili|electropermeabili
-
Irreversible Pore Formation and Cell Death ECT 15IRE 924
irreversible electroporation · IRE · non thermal ablation · non-thermal ablation · nonthermal ablation · pulsed field ablation · pulsed-field ablation · PFA
Search pattern: irreversible electroporation|\bIRE\b|non[- ]?thermal ablation|pulsed[- ]field ablation|\bPFA\b
-
Nanosecond Pulsed Electric Field (nsPEF) ECT 6IRE 7
nanosecond pulsed electric field · nsPEF · picosecond pulse
Search pattern: nanosecond pulsed electric field|nsPEF|picosecond pulse
-
Transmembrane Potential Change ECT 5IRE 13
transmembrane voltage · transmembrane potential · induced transmembrane
Search pattern: transmembrane (voltage|potential)|induced transmembrane
Drug Transport 4 names
-
Increased Intracellular Bleomycin Accumulation ECT 465IRE 11
bleomycin
Search pattern: bleomycin
-
Increased Intracellular Cisplatin Accumulation ECT 180IRE 7
cisplatin · cis diamminedichloroplatinum · cis-diamminedichloroplatinum · cisdiamminedichloroplatinum · platinum uptake
Search pattern: cisplatin|cis[- ]?diamminedichloroplatinum|platinum uptake
-
Calcium Electroporation and ATP Depletion ECT 6IRE 3
calcium electroporation · calcium induced · calcium-induced · calciuminduced · ATP depletion
Search pattern: calcium electroporation|calcium[- ]?induced|ATP depletion
-
Potentiation of Cytotoxic Drug Permeability ECT 130IRE 24
drug uptake · drug delivery · drug accumulation · cytotoxicity enhancement · potentiat
Search pattern: drug (uptake|delivery|accumulation)|cytotoxicity enhancement|potentiat
Gene and Immune Pathways 5 names
-
Gene Electrotransfer (Plasmid DNA) ECT 20IRE 4
gene electrotransfer · electrogene · plasmid DNA · gene transfer · electrotransfection · DNA vaccine
Search pattern: gene electrotransfer|electrogene|plasmid DNA|gene transfer|electrotransfection|DNA vaccine
-
Interleukin-12 Mediated Immune Stimulation ECT 7IRE 0
interleukin 12 · interleukin-12 · interleukin12 · IL-12 · IL12
Search pattern: interleukin[- ]?12|\bIL-?12\b
-
Immunogenic Cell Death (ICD) ECT 16IRE 27
immunogenic cell death · calreticulin · damage associated molecular pattern · damage-associated molecular pattern · DAMP
Search pattern: immunogenic cell death|calreticulin|damage[- ]associated molecular pattern|\bDAMP
-
Systemic / Abscopal Immune Response ECT 35IRE 28
abscopal · systemic immune response · systemic immune effect · systemic antitumour response · systemic antitumour effect · systemic antitumor response · systemic antitumor effect · distant lesion · distant metasta
Search pattern: abscopal|systemic (immune|antitumou?r) (response|effect)|distant (lesion|metasta)
-
Immune Checkpoint Inhibitor Combination ECT 23IRE 19
checkpoint inhibitor · anti PD-L1 · anti PD-1 · anti PDL1 · anti PD1 · anti-PD-L1 · anti-PD-1 · anti-PDL1 · anti-PD1 · antiPD-L1 · antiPD-1 · antiPDL1 · antiPD1 · ipilimumab · pembrolizumab · nivolumab · CTLA-4 · CTLA4
Search pattern: checkpoint inhibitor|anti[- ]?PD-?[L]?1|ipilimumab|pembrolizumab|nivolumab|CTLA-?4
Vascular and Tissue Effects 6 names
-
Vascular Lock Effect ECT 17IRE 1
vascular lock · blood flow reduction · blood flow modif · vasoconstrict
Search pattern: vascular lock|blood flow (reduction|modif)|vasoconstrict
-
Antivascular Effect and Vessel Disruption ECT 15IRE 4
antivascular · vascular disrupt · tumour vasculature · tumour perfusion · tumor vasculature · tumor perfusion · endothelial damage
Search pattern: antivascular|vascular disrupt|tumou?r (vasculature|perfusion)|endothelial damage
-
Haemostasis and Bleeding Control ECT 17IRE 25
haemostas · hemostas · bleeding control · haemorrhag · hemorrhag
Search pattern: ha?emostas|bleeding control|ha?emorrhag
-
Preservation of Extracellular Matrix and Tissue Scaffold ECT 8IRE 34
extracellular matrix · scaffold preserv · collagen preserv · collagen spar · tissue architecture
Search pattern: extracellular matrix|scaffold preserv|collagen (preserv|spar)|tissue architecture
-
Preservation of Nerve and Vascular Structures ECT 1IRE 26
nerve spar · vessel spar · preservation of nerves · preservation of vital structures · critical structures · phrenic nerve · o?esophag\w* (injur|spar|protect|fistula) · collateral damage · collateral injur
Search pattern: nerve spar|vessel spar|preservation of (nerves|vital structures)|critical structures|phrenic nerve|o?esophag\w* (injur|spar|protect|fistula)|collateral (damage|injur)
-
Increased Blood–Brain Barrier Permeability ECT 0IRE 15
blood brain barrier · blood-brain barrier · BBB
Search pattern: blood[- ]brain barrier|\bBBB\b
Cell Death Pathways 5 names
-
Apoptosis Induction ECT 43IRE 90
apoptosis · apoptotic · caspase
Search pattern: apoptosis|apoptotic|caspase
-
Necrosis and Necroptosis ECT 70IRE 73
necrosis · necroptosis · coagulative necro
Search pattern: necrosis|necroptosis|coagulative necro
-
DNA Damage and Double-Strand Breaks ECT 4IRE 1
DNA damage · DNA double strand break · DNA double-strand break · genotoxic · γH2AX · gamma-H2AX
Search pattern: DNA (damage|double[- ]strand break)|genotoxic|γH2AX|gamma-H2AX
-
Mitochondrial Dysfunction and Oxidative Stress ECT 13IRE 19
mitochondri · reactive oxygen species · oxidative stress · ROS
Search pattern: mitochondri|reactive oxygen species|oxidative stress|\bROS\b
-
Disruption of Calcium Homeostasis ECT 1IRE 3
calcium homeostasis · calcium influx · calcium overload · intracellular Ca
Search pattern: calcium (homeostasis|influx|overload)|intracellular Ca
Dose and Device 6 names
-
Electric Field Distribution and Modelling ECT 85IRE 134
electric field distribution · field strength · finite element · finite-element · numerical model · numerical simulation · treatment planning
Search pattern: electric field distribution|field strength|finite[- ]element|numerical (model|simulation)|treatment planning
-
Electrode Geometry and Placement ECT 85IRE 63
electrode design · electrode geometry · electrode configuration · electrode array · electrode placement · needle electrode · plate electrode
Search pattern: electrode (design|geometry|configuration|array|placement)|needle electrode|plate electrode
-
Tissue Conductivity and Impedance Change ECT 31IRE 56
conductivity · impedance · resistance change · current density
Search pattern: conductivity|impedance|resistance change|current density
-
Optimisation of Pulse Parameters ECT 81IRE 90
pulse parameter · pulse duration · pulse number · pulse amplitude · pulse repetition · pulse width · \d+\s*Hz · train of pulses
Search pattern: pulse (parameter|duration|number|amplitude|repetition|width)|\d+\s*Hz|train of pulses
-
Thermal Effect and Joule Heating ECT 3IRE 102
joule heating · thermal effect · thermal damage · thermal injury · temperature rise · temperature increase
Search pattern: joule heating|thermal (effect|damage|injury)|temperature (rise|increase)
-
Muscle Contraction and Anaesthesia Requirement ECT 84IRE 47
muscle contraction · neuromuscular · general anaesthesia · general anesthesia · sedation
Search pattern: muscle contraction|neuromuscular|general ana?esthesia|sedation
Outcome domains
-
Objective response ECT 43IRE 3
objective response · overall response rate · ORR · response rate · partial response
Search pattern: objective response|overall response rate|\bORR\b|response rate|partial response
-
Complete response ECT 50IRE 3
complete response · complete remission · complete regression
Search pattern: complete response|complete remission|complete regression
-
Local tumour control ECT 35IRE 10
local tumour control · local tumor control · local control · locoregional control · locally controlled · local controlled
Search pattern: local (?:tumou?r )?control|locoregional control|local(?:ly)? controlled
-
Local recurrence ECT 19IRE 19
local recurrence · recurrence free · recurrence-free · local relapse · re-treatment · retreatment
Search pattern: local recurrence|recurrence[- ]free|local relapse|re-?treatment
-
Survival ECT 25IRE 37
overall survival · progression free survival · progression-free survival · disease free survival · disease-free survival · median survival
Search pattern: overall survival|progression[- ]free survival|disease[- ]free survival|median survival
-
Symptom control and palliation ECT 74IRE 12
symptom control · pain relief · pain control · pain reduction · bleeding control · haemostasis · hemostasis · palliat
Search pattern: symptom control|pain (?:relief|control|reduction)|bleeding control|ha?emostasis|palliat
-
Quality of life ECT 33IRE 20
quality of life · QoL · EORTC QLQ · patient reported outcome · patient-reported outcome
Search pattern: quality of life|\bQoL\b|EORTC QLQ|patient[- ]reported outcome
-
Safety and tolerability ECT 69IRE 38
adverse event · toxicit · safety profile · tolerab · complication rate · side effect
Search pattern: adverse event|toxicit|safety profile|tolerab|complication rate|side effect
-
Organ and tissue preservation ECT 0IRE 0
organ preservation · sphincter preserv · sphincter-preserv · function preserv · function-preserv · functionpreserv · limb salvage
Search pattern: organ preservation|sphincter[- ]preserv|function[- ]?preserv|limb salvage
-
Cosmetic and functional outcome ECT 16IRE 16
cosmetic outcome · cosmetic result · functional outcome · wound healing · scar
Search pattern: cosmetic (?:outcome|result)|functional outcome|wound healing|scar